Life-Changing Results with MSC Therapy: Dysautonomia Awareness Month

Used in over 10,000 therapies to date, Celltex-produced Mesenchymal Stem Cells (MSCs) have changed the lives of people around the world, all with varying conditions and medical needs.

Mikaela Aschoff is one of these clients, who at age 14 was diagnosed with dysautonomia, a disorder that disrupts the autonomic nervous system. For years she struggled with seizures, severe fatigue, migraines, brain fog, and many other symptoms that disrupted her life. She eventually found Celltex and saw life-changing results following stem cell therapy.

Join this webinar where we recognize Dysautonomia Awareness Month and speak to Mikaela about her incredible story and how she is feeling today.

Celltex Chief Medical Officer Dr. Stanley Jones, who played a key role in Mikaela’s recovery, also joins to provide a medical perspective on the properties of MSCs that are promising for a range of clinical applications.

Click above to register for this webinar.

ABOUT THE GUESTS: Mikaela Aschoff

Celltex Client with Dysautonomia

Mikaela Aschoff is a Celltex client with dysautonomia, a disorder that disrupts the autonomic nervous system, causing a range of symptoms like fatigue, nausea, indigestion, and insomnia.

In 2010, at her freshman year homecoming dance, Mikaela suddenly collapsed. This strange but alarming medical event soon developed into syncope episodes, severe fatigue, widespread pain, seizures, migraines, brain fog, and gastroparesis.

As her condition worsened, doctors eventually diagnosed her with dysautonomia. She was wheelchair-bound and could not live like a normal teenager. The treatments she had tried were largely ineffective and she feared she’d never be able to attend college. Then she found Celltex.

After her first round of stem cell therapy, Mikaela immediately noticed small improvements that only became more significant over time. Her energy increased, pain reduced, syncope episodes and seizures became rare, and after only five months she was out of her wheelchair.

Tune in to this webinar to hear more about Mikaela’s story, as she provides updates on how she’s feeling today.

Stanley C. Jones, MD

Chief Medical Officer, Celltex Therapeutics

Dr. Stanley Jones serves as the Celltex Chief Medical Officer and a board-certified orthopedic spine surgeon. After suffering from a sudden onset of psoriatic arthritis, which prevented him from performing surgeries at full capacity, Jones traveled to South Korea to receive the treatment of his own stem cells. This treatment allowed him to return to a normal surgery schedule and enjoy life pain-free. Dr. Jones was soon motivated to help bring stem cell technology to the state of Texas, so that more individuals could experience the quality of life improvements that he saw. Through these efforts, he has gained extensive knowledge on the clinical applications of stem cells.

Dr. Jones received a B.A. in chemistry from Texas Tech University and an M.D. from the University of Texas Southwestern Medical School. He completed an internship at the University of Utah and an orthopedic residency at the University of Texas Medical School in Houston. He then served in the U.S. Army as a Captain in the Medical Corps.

Register Now